Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta

Kenshi Yamasaki1, Nobuko Toriu, Yasushi Hanakawa

  • 1Department of Dermatology, Ehime University School of Medicine, Ehime, Japan. yamasaki@m.ehime-u.ac.jp

Insights

High doses of epidermal growth factor (EGF) inhibit keratinocyte growth by activating an autocrine transforming growth factor beta1 (TGF-β1) pathway. This TGF-β1-ALK5 signaling acts as a negative feedback loop in normal human keratinocytes.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Dermatology

Background:

  • Epidermal growth factor receptor (EGFR) signaling regulates keratinocyte proliferation.
  • High-dose EGF ligands typically inhibit keratinocyte growth.
  • Previous studies implicated STAT1 in EGF-induced growth arrest in cancer cells, but not normal keratinocytes.

Purpose of the Study:

  • To investigate the role of transforming growth factor beta (TGF-β) in EGF-mediated keratinocyte growth inhibition.
  • To elucidate the signaling pathway involved in EGF-induced growth arrest in normal human keratinocytes.

Main Methods:

  • Stimulation of normal human keratinocytes with varying doses of EGF.
  • Measurement of TGF-β1 mRNA expression and protein levels.
  • Analysis of TGF-β-Smad signaling using a p3TP-lux reporter assay.
  • Inhibition of TGF-β type I receptor (ALK5) using an adenovirus vector (AxdnALK5).

Main Results:

  • EGF (10-100 ng/ml) significantly increased TGF-β1 mRNA and protein expression in keratinocytes.
  • EGF upregulated TGF-β-Smad signaling activity in a dose-dependent manner.
  • Inhibition of ALK5 blocked EGF-induced growth inhibition in normal keratinocytes.
  • EGF-induced TGF-β1 acts in an autocrine fashion.

Conclusions:

  • An autocrine TGF-β1-ALK5 pathway mediates EGF-induced growth inhibition in normal human keratinocytes.
  • This pathway serves as a negative feedback mechanism for EGF signaling.
  • Findings contrast with STAT1-dependent mechanisms observed in cancer cell lines.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cells of the Epidermis01:24

Cells of the Epidermis

The epidermis is made of four or five layers of epithelial cells, depending on its location in the body. From deep to superficial, these layers are the stratum basale, stratum spinosum, stratum granulosum, stratum lucidum, and stratum corneum.
The cells in all these layers except the stratum basale are called keratinocytes, a type of cell that manufactures and stores the protein keratin. The keratinocytes in the stratum corneum are dead and regularly slough away, being replaced by cells from...